Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.eResearchTechnology (ERT), a provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations and a provider of centralized cardiac safety and respiratory efficacy services in drug development ,has reported total net revenues of $44.9m for the fourth quarter ended 31 December 2010, compared to $23.14m for the same period in 2009.
Subscribe to our email newsletter
ERT has posted gross margin of $19.71m for the fourth quarter of 2010, compared to $13.17m for the same period in 2009.
The company has generated net income of $4.12m, compared to $3.25m for the same period in 2009.
For the full year ended 31 December 2010, the company posted total net revenues of $140.99m, compared to $93.82m for the same period in 2009.
ERT’s net income was $9.87m, compared to $10.69m for the same period in 2009.
ERT chairman and interim CEO Joel Morganroth said they continue to execute strategic plan of leveraging expertise in the collection, processing and distribution of digital clinical data and applying that knowledge to other healthcare sectors.